FDA Investigating Reports Of COVID Relapses Following Use Of Pfizer’s Pill
The US FDA has launched an investigation after reports of COVID relapses in patients within 5 to 9 days following the use of Pfizer’s pill known as nirmatrelvir.
Tag: Nirmatrelvir